Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/83966 |
Resumo: | OBJECTIVE: Here, we describe our experience with different therapeutic modalities used to treat cystic lymphangiomas in children in our hospital, including single therapy with OK-432, bleomycin and surgery, and a combination of the three modalities. METHODS: We performed a retrospective, cross-sectional study including patients treated from 1998 to 2011. The effects on macrocystic lymphangiomas and adverse reactions were evaluated. Twenty-nine children with cystic lymphangiomas without any previous treatment were included. Under general anesthesia, patients given sclerosing agents underwent puncture of the lesion (guided by ultrasound when necessary) and complete aspiration of the intralesional liquid. The patients were evaluated with ultrasound and clinical examinations for a maximum follow-up time of 4 years. RESULTS: The proportions of patients considered cured after the first therapeutic approach were 44% in the surgery group, 29% in the bleomycin group and 31% in the OK-432 group. These proportions were not significantly different. Sequential treatment increased the rates of curative results to 71%, 74% and 44%, respectively, after the final treatment, which in our case was approximately 1.5 applications per patient. CONCLUSION: The results of this study indicate that most patients with cystic lymphangiomas do not show complete resolution after the initial therapy, regardless of whether the therapy is surgical or involves the use of sclerosing agents. To achieve complete resolution of the lesions, either multiple operations or a combination of surgery and sclerotherapy must be used and should be tailored to the characteristics of each patient. |
id |
USP-19_d16c6a5350f694c6186487ebdf3f7d1f |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/83966 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children OBJECTIVE: Here, we describe our experience with different therapeutic modalities used to treat cystic lymphangiomas in children in our hospital, including single therapy with OK-432, bleomycin and surgery, and a combination of the three modalities. METHODS: We performed a retrospective, cross-sectional study including patients treated from 1998 to 2011. The effects on macrocystic lymphangiomas and adverse reactions were evaluated. Twenty-nine children with cystic lymphangiomas without any previous treatment were included. Under general anesthesia, patients given sclerosing agents underwent puncture of the lesion (guided by ultrasound when necessary) and complete aspiration of the intralesional liquid. The patients were evaluated with ultrasound and clinical examinations for a maximum follow-up time of 4 years. RESULTS: The proportions of patients considered cured after the first therapeutic approach were 44% in the surgery group, 29% in the bleomycin group and 31% in the OK-432 group. These proportions were not significantly different. Sequential treatment increased the rates of curative results to 71%, 74% and 44%, respectively, after the final treatment, which in our case was approximately 1.5 applications per patient. CONCLUSION: The results of this study indicate that most patients with cystic lymphangiomas do not show complete resolution after the initial therapy, regardless of whether the therapy is surgical or involves the use of sclerosing agents. To achieve complete resolution of the lesions, either multiple operations or a combination of surgery and sclerotherapy must be used and should be tailored to the characteristics of each patient. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/8396610.6061/clinics/2014(08)01Clinics; Vol. 69 No. 8 (2014); 505-508Clinics; v. 69 n. 8 (2014); 505-508Clinics; Vol. 69 Núm. 8 (2014); 505-5081980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/83966/86798Olímpio, Hugo de Oliveira Bustorff-Silva, Joaquim Oliveira Filho, Antonio Gonçalves de Araujo, Kleber Cursino de info:eu-repo/semantics/openAccess2014-08-26T22:46:18Zoai:revistas.usp.br:article/83966Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2014-08-26T22:46:18Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children |
title |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children |
spellingShingle |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children Olímpio, Hugo de Oliveira |
title_short |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children |
title_full |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children |
title_fullStr |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children |
title_full_unstemmed |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children |
title_sort |
Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children |
author |
Olímpio, Hugo de Oliveira |
author_facet |
Olímpio, Hugo de Oliveira Bustorff-Silva, Joaquim Oliveira Filho, Antonio Gonçalves de Araujo, Kleber Cursino de |
author_role |
author |
author2 |
Bustorff-Silva, Joaquim Oliveira Filho, Antonio Gonçalves de Araujo, Kleber Cursino de |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Olímpio, Hugo de Oliveira Bustorff-Silva, Joaquim Oliveira Filho, Antonio Gonçalves de Araujo, Kleber Cursino de |
description |
OBJECTIVE: Here, we describe our experience with different therapeutic modalities used to treat cystic lymphangiomas in children in our hospital, including single therapy with OK-432, bleomycin and surgery, and a combination of the three modalities. METHODS: We performed a retrospective, cross-sectional study including patients treated from 1998 to 2011. The effects on macrocystic lymphangiomas and adverse reactions were evaluated. Twenty-nine children with cystic lymphangiomas without any previous treatment were included. Under general anesthesia, patients given sclerosing agents underwent puncture of the lesion (guided by ultrasound when necessary) and complete aspiration of the intralesional liquid. The patients were evaluated with ultrasound and clinical examinations for a maximum follow-up time of 4 years. RESULTS: The proportions of patients considered cured after the first therapeutic approach were 44% in the surgery group, 29% in the bleomycin group and 31% in the OK-432 group. These proportions were not significantly different. Sequential treatment increased the rates of curative results to 71%, 74% and 44%, respectively, after the final treatment, which in our case was approximately 1.5 applications per patient. CONCLUSION: The results of this study indicate that most patients with cystic lymphangiomas do not show complete resolution after the initial therapy, regardless of whether the therapy is surgical or involves the use of sclerosing agents. To achieve complete resolution of the lesions, either multiple operations or a combination of surgery and sclerotherapy must be used and should be tailored to the characteristics of each patient. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/83966 10.6061/clinics/2014(08)01 |
url |
https://www.revistas.usp.br/clinics/article/view/83966 |
identifier_str_mv |
10.6061/clinics/2014(08)01 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/83966/86798 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 69 No. 8 (2014); 505-508 Clinics; v. 69 n. 8 (2014); 505-508 Clinics; Vol. 69 Núm. 8 (2014); 505-508 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222761235251201 |